SYNE4 Gene Deafness autosomal recessive type 76 Genetic Test
At DNA Labs UAE, we offer the SYNE4 Gene Deafness autosomal recessive type 76 Genetic Test. This test is designed to identify any mutations or variations in the SYNE4 gene that may be causing hearing loss.
Test Components and Price
The test is priced at 4400.0 AED. The sample condition can be either blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
The report will be delivered within 3 to 4 weeks. The test is conducted using NGS (Next-Generation Sequencing) technology.
Test Type and Doctor
The SYNE4 Gene Deafness autosomal recessive type 76 Genetic Test falls under the category of Ear Nose Throat Disorders. It is recommended to consult with an ENT Doctor for this test.
Test Department and Pre Test Information
The test is conducted in our Genetics department. Prior to the test, it is important to provide the clinical history of the patient who is going for the SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A13.
Test Details
The SYNE4 gene is associated with autosomal recessive deafness type 76 (DFNB76). This genetic disorder affects the development and function of the inner ear, leading to hearing loss. The NGS genetic test can identify any mutations or variations in the SYNE4 gene that may be causing the hearing loss.
NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous sequencing of multiple genes or the entire genome. In the case of SYNE4 gene deafness, an NGS genetic test can be used for diagnostic purposes to confirm a suspected genetic cause of hearing loss. It can also be used for carrier screening to identify individuals who carry a single copy of the mutated gene and are at risk of passing it on to their children.
The test involves obtaining a DNA sample, often through a blood or saliva sample, from the individual undergoing testing. The DNA is then sequenced using NGS technology to identify any variations or mutations in the SYNE4 gene.
Management and Counseling
If a mutation or variation in the SYNE4 gene is identified, healthcare professionals can provide appropriate management and counseling for individuals with autosomal recessive deafness type 76. This may include hearing aids, cochlear implants, or other interventions to help manage the hearing loss.
It’s important to note that genetic testing for SYNE4 gene deafness is typically only recommended for individuals with symptoms of hearing loss or a family history of the condition. Genetic testing should be done under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and support.
| Test Name | SYNE4 Gene Deafness autosomal recessive type 76 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A13 |
| Test Details |
The SYNE4 gene is associated with autosomal recessive deafness type 76 (DFNB76). This genetic disorder affects the development and function of the inner ear, leading to hearing loss. NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous sequencing of multiple genes or the entire genome. In the case of SYNE4 gene deafness, an NGS genetic test can identify any mutations or variations in the SYNE4 gene that may be causing the hearing loss. The NGS genetic test for SYNE4 gene deafness can be used for diagnostic purposes to confirm a suspected genetic cause of hearing loss. It can also be used for carrier screening, which can help identify individuals who carry a single copy of the mutated gene and are at risk of passing it on to their children. The test typically involves obtaining a DNA sample, often through a blood or saliva sample, from the individual undergoing testing. The DNA is then sequenced using NGS technology to identify any variations or mutations in the SYNE4 gene. If a mutation or variation in the SYNE4 gene is identified, it can help healthcare professionals provide appropriate management and counseling for individuals with autosomal recessive deafness type 76. This may include hearing aids, cochlear implants, or other interventions to help manage the hearing loss. It’s important to note that genetic testing for SYNE4 gene deafness is typically only recommended for individuals with symptoms of hearing loss or a family history of the condition. Genetic testing should be done under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and support. |
